Poland· PL-100004319

Alugastrin

A aluminium-natrium-carbonat-dihydroxid product containing dihydroxyaluminii natrii carbonas, registered in Poland by URGO Sp. z o.o.. The same ATC class is registered in 3 of our 19 countries.

ATC A02AB04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAlugastrinATCA02AB04REGISTER NO.PL-100004319PACKS LISTED6CHECKEDSeptember 27, 2026

Where it is registered

Aluminium-natrium-carbonat-dihydroxid is registered in 3 of 19 countries.

Countries holding a registration under ATC A02AB04 (aluminium-natrium-carbonat-dihydroxid), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose

Aluminium-natrium-carbonat-dihydroxid · ATC A02AB04

3 / 19 countries

  • Denmark
  • Finlandprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Dihydroxyaluminii natrii carbonas
Manufacturer
URGO Sp. z o.o.
Country
Poland (PL)
ATC code
A02AB04
ATC class
Aluminium-Natrium-Carbonat-Dihydroxid
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909990292028
  • gtin
    05909990292011
  • gtin
    05909990292035
  • gtin
    05909990292042
  • gtin
    05909991202675
  • gtin
    05902020314707

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A02AB04

Aluminium-natrium-carbonat-dihydroxid, as other registers publish it.

All aluminium-natrium-carbonat-dihydroxid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cdc83d9c-b510-4bb8-a472-ef8a48e78625
GET /v1/drugs/cdc83d9c-b510-4bb8-a472-ef8a48e78625?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki do rozgryzania i żucia",
  "source": "urpl",
  "strength": "340 mg",
  "packaging": "05909990292028 ¦ OTC ¦ Skasowane ¦ 680\n40 tabl.\n05909990292011 ¦ OTC ¦ Skasowane ¦ 14344\n20 tabl.\n05909990292035 ¦ OTC ¦ 46113\n20 tabl.\n05909990292042 ¦ OTC ¦ 46114\n40 tabl.\n05909991202675 ¦ OTC ¦ 105862\n60 tabl.\n05902020314707 ¦ OTC ¦ 129521\n10 tabl. (1 x 10)",
  "substance": "Dihydroxyaluminii natrii carbonas 340 mg",
  "common_name": "Dihydroxyaluminii natrii carbonas",
  "pl_product_id": "100004319",
  "pozwolenie_nr": "02920",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about aluminium-natrium-carbonat-dihydroxid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.